Kenya Seeks to Become Africa’s Vaccine Hub with New $250 Million Facility and Digital Health Plan
According to a statement from Hon. William Kabogo Gitau, these collaborations are crucial for charting a path where science, technology, and innovation can drive healthcare solutions for Africa and beyond.
A high-level bilateral meeting was held this morning to discuss strategic partnerships aimed at strengthening Kenya’s bio-vaccine research and digital health systems. The meeting, hosted by Health Cabinet Secretary Hon. Aden Duale and Hon. William Kabogo Gitau, brought together delegations from the Korea Advanced Institute of Science & Technology (KAIST) and the International Vaccine Institute (IVI). The IVI delegation was led by Dr. Jerome Kim.
Discussions focused on several key areas, including the establishment of a $250 million vaccine manufacturing facility at Konza Technopolis. The goal is to position Kenya as a regional hub for vaccine production, leveraging the nation’s active role in the IVI Global Council to influence the future of global vaccine development.
The talks also explored how to integrate emerging technologies into Kenya’s healthcare system. This includes fostering innovation through the Kenya-AIST initiative and incorporating AI-powered biomedical research into the country’s Digital Economy Blueprint. The partnership also emphasized the need for strong policies to protect health data systems.
According to a statement from Hon. William Kabogo Gitau, these collaborations are crucial for charting a path where science, technology, and innovation can drive healthcare solutions for Africa and beyond.
